One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
      • Luxury & premium products
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Healthcare IT
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
    • Automotive and Transportation
      • Automotive components
      • Automotive Logistics
      • Automotive systems and accessories
    • Information and Communications Technology
      • E Commerce and Outsourcing
      • Entertainment & Media
      • High Tech | Enterprise & Consumer IT
      • Information & Network Security
      • Mobility | Telecom & Wireless
      • Software and Services
    • Semiconductor and Electronics
      • Semiconductor Materials and Components
      • Display Technology
      • Electronics System and Components
      • Emerging technologies
      • Security and Surveillance
      • Sensors and Controls
    • Building and Construction
      • Construction Materials
      • HVAC
      • Residential Construction and Improvement
      • Roads & Highways
    • Manufacturing
      • Manufacturing Services
      • Heavy Manufacturing
      • Packaging
      • Engineering | Equipment and Machinery
  • Who Trust Us
  • [email protected]
  • +1 718 874 1545 (International)
  • +91 78878 22626 (Asia)

More Results

One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
      • Luxury & premium products
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Healthcare IT
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
    • Automotive and Transportation
      • Automotive components
      • Automotive Logistics
      • Automotive systems and accessories
    • Information and Communications Technology
      • E Commerce and Outsourcing
      • Entertainment & Media
      • High Tech | Enterprise & Consumer IT
      • Information & Network Security
      • Mobility | Telecom & Wireless
      • Software and Services
    • Semiconductor and Electronics
      • Semiconductor Materials and Components
      • Display Technology
      • Electronics System and Components
      • Emerging technologies
      • Security and Surveillance
      • Sensors and Controls
    • Building and Construction
      • Construction Materials
      • HVAC
      • Residential Construction and Improvement
      • Roads & Highways
    • Manufacturing
      • Manufacturing Services
      • Heavy Manufacturing
      • Packaging
      • Engineering | Equipment and Machinery
  • Who Trust Us
Home ➤ Life Science ➤ Healthcare ➤ Bioprosthetics Market
Bioprosthetics Market
Bioprosthetics Market
Published date: Dec 2023 • Formats:
Request Sample Schedule a Call
  • Home ➤ Life Science ➤ Healthcare ➤ Bioprosthetics Market

Global Bioprosthetics Market By Type(Allograft, Xenograft)By Application-(Cardiovascular, Plastic surgery & wound healing) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

  • Published date: Dec 2023
  • Report ID: 53445
  • Number of Pages: 221
  • Format:
  • Overview
  • Table of Contents
  • Major Market Players
  • Request a Free Sample
  • Quick Navigation

    • Market Overview
    • Key Takeaways
    • Type Analysis
    • Application Analysis
    • Маrkеt Ѕеgmеntѕ
    • Driver
    • Trend
    • Restriction
    • Opportunity
    • Technological Innovation
    • Regional Analysis
    • Key Player Analysis
    • Recent Development
    • Report Scope

    Market Overview

    The Global Bioprosthetics Market size is expected to be worth around USD 16.6 Billion by 2033 from USD 5.9 Billion in 2023, growing at a CAGR of 10.9% during the forecast period from 2023 to 2033.

    Bioprosthetics refers to the incorporation of animal or human tissue for medical implants, featuring significant advances in this market. Implanted parts gradually degrade, prompting formation of new tissue in their place – this process not only replaces them but also encourages regeneration while showing healthy characteristics and encouraging angiogenesis.

    Increased cardiovascular diseases due to unhealthy lifestyles and diet have propelled market expansion. Furthermore, an expanding geriatric population that often experiences tissue damage and cardiovascular problems further drives market expansion. Substantial investments in research and development fuel technological progress with innovations like hybrid tissue-engineered bioprostheses made with nonbiodegradable scaffolds for greater resistance and durability often preferred over mechanical alternatives.

    Technological advances combined with unhealthy lifestyles are two key drivers for the bioprosthetics market. Sophisticated techniques allow faster recovery rates and greater patient safety, creating a preference for this technology among both patients and physicians. Furthermore, factors like forecasted increases in cardiovascular illnesses due to unhealthy lifestyles; as well as public awareness campaigns; are further driving this market forward.

    Bioprosthetics Market Size

    *Actual Numbers Might Vary In The Final Report

    Key Takeaways

    • Market Size & Growth: Bioprosthetics Market size is expected to be worth around USD 16.6 Billion by 2033 from USD 5.9 Billion in 2023, growing at a CAGR of 10.9%.
    • Type Analysis: Allograft implants held a significant market share of more than 68% by 2023.
    • Application Analysis: In 2023, cardiovascular applications of bioprosthetics held an impressive share of over 84%.
    • Regional Analysis: Europe dominated the global bioprosthetics Market in 2023 with a greater than 41.1% share and holding approx USD 2.4 Bn revenue.
    • Key Market Trends: Tissue-engineered bioprostheses, decellularized materials and hybrid bioprostheses have emerged as promising trends in the market.
    • Future Outlook: Technological advancements, increased demand for minimally invasive procedures and greater awareness of cardiovascular diseases will continue to shape the market landscape.

    Type Analysis

    Allograft implants held a significant market share of more than 68% by 2023, thanks to their many advantages such as long-term stability, easy availability of raw materials, higher survival rates, lower manufacturing costs, and straightforward implantation procedures. All of these advantages made Allograft an obvious choice among bioprosthetics available on the market, and also led to its widespread application such as creating personalized 3D-printed implants and tissue repair applications.

    Porcine-based devices within the Allograft segment are expected to experience rapid growth at an impressive compound annual growth rate over the forecast period, due in large part to clinical studies by organizations like American Heart Association that aim at increasing efficacy while mitigating common adverse effects associated with porcine Allograft implants and devices. Such initiatives should further support market penetration of porcine Allograft devices.

    Application Analysis

    In 2023, cardiovascular applications of bioprosthetics held an impressive share of over 84%. This growth can be attributed to an increasing number of patients suffering from cardiovascular conditions who require valve replacement procedures and their increasing numbers needing minimally invasive techniques with groundbreaking advances in second generation bioprosthetics aimed at minimizing structural failures – all factors which are expected to drive demand for bio-implants during the forecast period.

    Bioprosthetic heart valves have played a key role in decreasing open-heart surgeries, leading to their dominance of this segment and contributing significantly to its dominance of market share. This shift demonstrates an ongoing trend toward innovative cardiovascular care solutions which is expected to shape its market landscape going forward.

    Bioprosthetics Market Share

    *Actual Numbers Might Vary In The Final Report

    Маrkеt Ѕеgmеntѕ

    Type

    • Allograft
    • Xenograft

    Application

    • Cardiovascular
    • Plastic surgery & wound healing

    Driver

    Technological Advancements in Bioprosthetics

    Bioprosthetics market growth is driven primarily by advances in technology. This includes innovations in tissue engineering, biomaterials and surgical techniques that lead to more sophisticated bioprosthetic devices; for instance integrating non-biodegradable scaffolds in hybrid tissue-engineered bioprostheses increases durability and resistance compared to mechanical materials; these technological developments result in faster recovery rates, increased patient safety and overall improvements – further cementing bioprosthetics’ place as a favored choice.

    Another exciting development within this technological field is personalized bioprosthetics. Tailoring implants specifically to meet each patient’s unique characteristics and needs improves efficacy and compatibility while opening new avenues for market expansion by catering to various medical conditions.

    Trend

    Customization and Personalization of Allografts

    Tailoring allografts to meet individual patient needs by customizing and personalizing is a significant opportunity. Thanks to advancements in precision medicine and tissue engineering techniques, allografts that closely mirror individual patient characteristics may now be created, leading to increased outcomes with greater acceptance among both healthcare providers and patients alike.

    Restriction

    Limited Access to Raw Materials

    Bioprosthetics market players face one significant restraint – limited availability of suitable raw materials sourced from biological sources (animal or human tissues), creating challenges in terms of manufacturing scale and consistency. Securing high-quality and ethically sourced raw materials remains an issue, limiting market players from producing large-scale bioprosthetics production, which necessitates innovative solutions and sustainable sourcing practices in order to enable sustainable market expansion.

    Opportunity

    Aging Population and Increased Incidence of Cardiovascular Diseases

    An enormous opportunity lies within the demographic shift to an aging population and rising cardiovascular diseases. As more of our global population ages, they become susceptible to tissue damage and cardiovascular issues which fuels demand for bioprosthetic solutions. Unfortunately, unhealthy lifestyles contribute to an increase in cardiovascular illnesses – providing bioprosthetic manufacturers with an enormous market opportunity.

    This demographic and health trend underscores the opportunity for market expansion and targeted bioprosthetic solutions that address specific healthcare challenges. Furthermore, greater public awareness regarding advanced medical technologies presents an avenue for market penetration and expansion.

    Technological Innovation

    Hybrid tissue-engineered bioprostheses have been developed through technological innovation. These include the use of nonbiodegradable cultured tissue scaffolds that contain an alloy of titanium and nickel. They are highly durable alternatives to biodegradable tissue-engineered prosthetics.

    These advancements will eventually replace the use of mechanical heart valves that are purely synthetic. They have been associated with high thrombogenicity, so it is necessary to administer anticoagulants to prevent embolic events, valve obstruction, bleeding, and other complications.

    These innovative solutions will reduce mortality and morbidity related to cardiac valve disorders. This is expected to increase the market for bioprosthetics during the forecast period. The prostheses will also be stronger due to the use of optimized tissue treatment methods. This will reduce the need for long-term medications that are often associated with prosthetics.

    The associated benefits, such as faster recovery rates and a relatively higher patient safety profile, are due to the development of hybrid constructs. These tissue-engineered products also have optimized tissue preservation techniques.

    This is expected to increase physician and patient preference for implantable bioprostheses. This market will see lucrative growth opportunities due to the increased preference of the medical community for these prostheses. The market will also benefit from the growing demand for various prostheses due to the increasing number of heart valve diseases and aortic valve replacements.

    Regional Analysis

    Europe dominated the global bioprosthetics Market in 2023 with a greater than 41.1% share and holding approx USD 2.4 Bn revenue . This large share is due to the presence of well-defined reimbursement models, prominent industry figures, and large patient volumes in the region. These devices will be in high demand due to the strict regulatory policies that are being implemented to ensure patient safety and maintain high treatment efficacy standards.

    Due to increasing awareness of alternative treatments and rapidly improving healthcare infrastructure, the Asia Pacific bioprosthetics industry is expected to grow at a CAGR exceeding 13.4%. This is due to the high level of research and development in emerging economies like India and China. The growing collaboration between global players in this sector and the government is slowly improving access to healthcare facilities. This will in turn provide the region with high growth potential over the forecast period.

    Bioprosthetics Market Region

    *Actual Numbers Might Vary In The Final Report

    Key Regions and Countries

    North America

    • The US
    • Canada
    • Mexico

    Western Europe

    • Germany
    • France
    • The UK
    • Spain
    • Italy
    • Portugal
    • Ireland
    • Austria
    • Switzerland
    • Benelux
    • Nordic
    • Rest of Western Europe

    Eastern Europe

    • Russia
    • Poland
    • The Czech Republic
    • Greece
    • Rest of Eastern Europe

    APAC

    • China
    • Japan
    • South Korea
    • India
    • Australia & New Zealand
    • Indonesia
    • Malaysia
    • Philippines
    • Singapore
    • Thailand
    • Vietnam
    • Rest of APAC

    Latin America

    • Brazil
    • Colombia
    • Chile
    • Argentina
    • Costa Rica
    • Rest of Latin America

    Middle East & Africa

    • Algeria
    • Egypt
    • Israel
    • Kuwait
    • Nigeria
    • Saudi Arabia
    • South Africa
    • Turkey
    • United Arab Emirates
    • Rest of MEA

    Key Player Analysis

    This Report offers an in-depth assessment of both established and emerging players in the bioprosthetics market. It offers listings of key companies categorized according to product offerings as well as market factors; additionally, analysts involved with creating this report profiled each company by their year of market entry for added insight.

    Маrkеt Key Рlауеrѕ

    • LeMaitre Vascular Inc.
    • Braile Biomedica Inc.
    • Labcor Laboratorios Ltd.
    • Maquet Metinge Group
    • Medtronic Plc.
    • Aortech International Plc
    • CryoLife Inc.
    • Sorin Group
    • Humacyte Inc.
    • Ethicon Inc.
    • Life Cell Corporation
    • Organogenesis Inc.
    • St. Jude Medical Inc.
    • Edwards Lifesciences Corporation
    • and JenaValve Technology GmbH.

    Recent Development

    • Edwards Lifesciences Corporation received FDA approval for their Intrepid Transcatheter Aortic Valve Replacement (TAVR) system in 2023. TAVR is a minimally invasive procedure using bioprosthetic valves to replace diseased aortic valves with new, biocompatible ones.
    • Medtronic plc was awarded FDA approval for their Perclose ProGlide Vascular Closure Device in 2022. This bioprosthetic closure device serves to close femoral artery access sites after transcatheter procedures, helping speed healing while decreasing complications risk.
    • Abbott Laboratories was awarded FDA approval for its Trifecta Rapid Deployment Valve (RDV). This bioprosthetic valve can replace diseased mitral valves quickly and with minimal complications; its design makes deployment quick and simple for faster outcomes.

    Report Scope

    Report Features Description
    Market Value (2023) USD 5.9 Billion
    Forecast Revenue (2033) USD 16.6 Billion
    CAGR (2024-2033) 10.6%
    Base Year for Estimation 2023
    Historic Period 2018-2022
    Forecast Period 2024-2033
    Report Coverage Revenue Forecast, Market Dynamics, Competitive Landscape, Recent Developments
    Segments Covered By Type(Allograft, Xenograft);By Application-(Cardiovascular, Plastic surgery & wound healing)
    Regional Analysis North America-US, Canada, Mexico;Europe-Germany, UK, France, Italy, Russia, Spain, Rest of Europe;APAC-China, Japan, South Korea, India, Rest of Asia-Pacific;South America-Brazil, Argentina, Rest of South America;MEA-GCC, South Africa, Israel, Rest of MEA
    Competitive Landscape LeMaitre Vascular Inc., Braile Biomedica Inc., Labcor Laboratorios Ltd., Maquet Metinge Group, Medtronic Plc., Aortech International Plc, CryoLife Inc., Sorin Group, Humacyte Inc., Ethicon Inc., Life Cell Corporation, Organogenesis Inc., St. Jude Medical Inc., Edwards Lifesciences Corporation, and JenaValve Technology GmbH.
    Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements.
    Purchase Options We have three licenses to opt for: Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF)

    Frequently Asked Questions (FAQ)

    What are Bioprosthetics?

    Bioprosthetics are medical implants made from biological materials, such as tissues or organs, to replace or support damaged biological structures in the body.

    How big is the Bioprosthetics Market?

    The global Bioprosthetics Market size was estimated at USD 5.9 Billion in 2023 and is expected to reach USD 16.6 Billion in 2033.

    What is the Bioprosthetics Market growth?

    The global Bioprosthetics Market is expected to grow at a compound annual growth rate of 10.6%. From 2024 To 2033

    Who are the key companies/players in the Bioprosthetics Market?

    Some of the key players in the Bioprosthetics Markets are LeMaitre Vascular Inc., Braile Biomedica Inc., Labcor Laboratorios Ltd., Maquet Metinge Group, Medtronic Plc., Aortech International Plc, CryoLife Inc., Sorin Group, Humacyte Inc., Ethicon Inc., Life Cell Corporation, Organogenesis Inc., St. Jude Medical Inc., Edwards Lifesciences Corporation, and JenaValve Technology GmbH.

    How do Bioprosthetics Work?

    Bioprosthetics work by integrating with the patient's body, gradually degrading over time while promoting the growth of new, natural tissue to replace the implanted material.

    What Applications are Common for Bioprosthetics?

    Bioprosthetics find applications in various medical fields, including cardiovascular surgery, orthopedics, and tissue repair procedures.

    What Drives the Growth of the Bioprosthetics Market?

    The market is driven by factors such as technological advancements, rising incidence of cardiovascular diseases, and an aging population with increased demand for tissue repair solutions.

    Bioprosthetics Market
    Bioprosthetics Market
    Published date: Dec 2023
    add_shopping_cartBuy Now get_appDownload Sample
    keyboard_arrow_up
    • LeMaitre Vascular Inc.
    • Braile Biomedica Inc.
    • Labcor Laboratorios Ltd.
    • Maquet Metinge Group
    • Medtronic Plc.
    • Aortech International Plc
    • CryoLife Inc.
    • Sorin Group
    • Humacyte Inc.
    • Ethicon Inc.
    • Life Cell Corporation
    • Organogenesis Inc.
    • St. Jude Medical Inc.
    • Edwards Lifesciences Corporation
    • and JenaValve Technology GmbH.
  • settingsSettings

Related Reports

  • Muscle Stimulator Market
  • Hospital-Acquired Infection Control Market
  • Clinical Workflow Solutions Market
  • Medical Cyclotron Market
  • Histology and Cytology Market
  • Life Sciences BPO Market

Our Clients

  • Our Clients
Inquiry Before Buying

Bioprosthetics Market
  • 53445
  • Dec 2023
    • ★★★★★
      ★★★★★
    • (58)
add_shopping_cart Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$6,000
$3,999
USD / per unit
save 24%
Multi User
$8,000
$5,999
USD / per unit
save 28%
Corporate User
$10,000
$6,999
USD / per unit
save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 3,999) Buy Now ($ 5,999) Buy Now ($ 6,999)
  • location_on420 Lexington Avenue, Suite 300 New York City, NY 10170,
    United States
  • phone+1 718 874 1545 (International)
  • phone+91 78878 22626 (Asia)
  • email[email protected]
  • Facebook Logo
  • Twitter Logo
  • LinkedIn Logo
Find Help
  • Contact Us
  • How to Order
Legal
  • Privacy Policy
  • Refund Policy
  • Frequently Asked Questions
  • Terms and Conditions
Explore
  • About Us
  • All Reports
  • All Sectors
  • Infographics
  • Statistics and Facts
  • Companies
Secured Payment Options
Secured Payment Options

© 2025 Market.Us. All Rights Reserved.